Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Clinical Medicine (London, England)
|
May 5, 2010
Bile acid malabsoption: a forgotten diagnosis?
Usman Khalid, Amyn Lalji, Ruth Stafferton, et al.
Clinical Therapeutics
|
January 30, 2010
Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire
Linda Wedlake, Karen Thomas, Amyn Lalji, et al.
Clinical Medicine (London, England)
|
December 2, 2015
Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome?
Lorraine Watson, Amyn Lalji, Shankar Bodla, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
May 13, 2017
Gastroenterologist and nurse management of symptoms after pelvic radiotherapy for cancer: an economic evaluation of a clinical randomized controlled trial (the ORBIT study)
Jake Jordan, Heather Gage, Barbara Benton, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 20, 2015
Outcomes from treating bile acid malabsorption using a multidisciplinary approach
Ankur Gupta, Ann C Muls, Amyn Lalji, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 17, 2010
Predicting late effects of pelvic radiotherapy: is there a better approach?
Linda J Wedlake, Karen Thomas, Amyn Lalji, et al.
Clinical Medicine (London, England)
|
October 5, 2017
The efficacy of a low-fat diet to manage the symptoms of bile acid malabsorption - outcomes in patients previously treated for cancer
Amy Jackson, Amyn Lalji, Mohammed Kabir, et al.
Clinical Medicine (London, England)
|
June 3, 2016
The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem?
Ann C Muls, Amyn Lalji, Christopher Marshall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2013
Letter in response to Dearnaley et al. letter regarding paper: Evaluating the efficacy of statins and angiotensin converting enzyme-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies
Linda J Wedlake, Foteini Silia, Barbara Benton, et al.
Lancet (London, England)
|
September 27, 2013
Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial
H Jervoise N Andreyev, Barbara E Benton, Amyn Lalji, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Clinical Medicine (London, England)
|
May 5, 2010
Bile acid malabsoption: a forgotten diagnosis?
Usman Khalid, Amyn Lalji, Ruth Stafferton, et al.
Clinical Therapeutics
|
January 30, 2010
Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire
Linda Wedlake, Karen Thomas, Amyn Lalji, et al.
Clinical Medicine (London, England)
|
December 2, 2015
Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome?
Lorraine Watson, Amyn Lalji, Shankar Bodla, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
May 13, 2017
Gastroenterologist and nurse management of symptoms after pelvic radiotherapy for cancer: an economic evaluation of a clinical randomized controlled trial (the ORBIT study)
Jake Jordan, Heather Gage, Barbara Benton, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 20, 2015
Outcomes from treating bile acid malabsorption using a multidisciplinary approach
Ankur Gupta, Ann C Muls, Amyn Lalji, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 17, 2010
Predicting late effects of pelvic radiotherapy: is there a better approach?
Linda J Wedlake, Karen Thomas, Amyn Lalji, et al.
Clinical Medicine (London, England)
|
October 5, 2017
The efficacy of a low-fat diet to manage the symptoms of bile acid malabsorption - outcomes in patients previously treated for cancer
Amy Jackson, Amyn Lalji, Mohammed Kabir, et al.
Clinical Medicine (London, England)
|
June 3, 2016
The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem?
Ann C Muls, Amyn Lalji, Christopher Marshall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2013
Letter in response to Dearnaley et al. letter regarding paper: Evaluating the efficacy of statins and angiotensin converting enzyme-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies
Linda J Wedlake, Foteini Silia, Barbara Benton, et al.
Lancet (London, England)
|
September 27, 2013
Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial
H Jervoise N Andreyev, Barbara E Benton, Amyn Lalji, et al.
Page
of 2